Alabama is now screenings newborns for two additional – and treatable – genetic disordersGetty Images/Cavan Images RF
Alabama is now screenings newborns for two additional – and treatable – genetic disorders. L-Homophenylalanine Homophe
According to the Alabama Department of Public Health, the screenings began March 13 to alert healthcare providers to the potential for conditions that are not typically apparent at birth. However, with blood screens and treatments, most affected babies have the opportunity to avoid death and disability and develop normally, ADPH said.
The two new newborn screenings are for:
READ MORE: Ivey proposes $400 rebates for Alabama taxpayers, millions for school facilities
Infants are also screened for some 50 conditions such as hypothyroidism, congenital adrenal hyperplasia, galactosemia, biotinidase deficiency, cystic fibrosis, sickle cell anemia and related hemoglobinopathies, amino acid disorders, fatty acid disorders, and organic acid disorders.
ADPH Bureau of Clinical Laboratories is the sole provider of blood analysis of newborns screenings in the state. The program identified 150-200 babies each year with metabolic, endocrine, hematological or other congenital disorder.
If you purchase a product or register for an account through one of the links on our site, we may receive compensation.
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your Privacy Choices and Rights (each updated 1/26/2023).
Cookie Settings/Do Not Sell My Personal Information
© 2023 Advance Local Media LLC. All rights reserved (About Us). The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local.
Community Rules apply to all content you upload or otherwise submit to this site.
Tert-Butoxycarbonyl YouTube’s privacy policy is available here and YouTube’s terms of service is available here.